AILEEN FISHER: Open Payments
NPI 1881783876 · GRAND PRAIRIE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,112 in 103 payments from 23 companies in 2025. Trend: 2023 $0 · 2024 $1,494 · 2025 $2,112
Food & beverage: $2,112
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 9 | $284 |
| Vanda Pharmaceuticals Inc. | 6 | $265 |
| Neurocrine BioSciences, Inc. | 12 | $244 |
| Teva Pharmaceuticals USA, Inc. | 10 | $210 |
| ABBVIE INC. | 21 | $199 |
| Otsuka America Pharmaceutical, Inc. | 8 | $166 |
| Soleno Therapeutics, Inc. | 4 | $117 |
| Almatica Pharma LLC | 5 | $92 |
| Lundbeck LLC | 4 | $69 |
| Tris Pharma Inc | 3 | $56 |
Products named: FANAPT, INVEGA SUSTENNA, INGREZZA, REXULTI, VRAYLAR, UZEDY, VYKAT XR, AUSTEDO XR.
Industry payments across TX — which companies pay providers there.
